Brady W. Dougan - Jun 13, 2023 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director, 10%+ Owner
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Stock symbol
HUMA
Transactions as of
Jun 13, 2023
Transactions value $
-$12,675,000
Form type
4
Date filed
6/15/2023, 04:19 PM
Previous filing
May 26, 2023
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HUMA Common Stock Sale -$12.7M -4.88M -31.73% $2.60 10.5M Jun 13, 2023 By Ayabudge LLC F1
holding HUMA Common Stock 510K Jun 13, 2023 Direct
holding HUMA Common Stock 1.27M Jun 13, 2023 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales were made by Ayabudge LLC, an entity controlled by Brady W. Dougan. The transactions enabled Mr. Dougan to pay down leverage while providing a mechanism for the institutional healthcare investor purchasers to acquire shares of the Issuer at a time that the Issuer was not conducting a financing transaction and was not making any additional shares available for purchase.